AU Patent

AU2010344973B2 — Hetaryl-[1,8]naphthyridine derivatives

Assigned to Merck Patent GmbH · Expires 2016-06-16 · 10y expired

What this patent protects

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R

USPTO Abstract

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R

Drugs covered by this patent

Xalkori (crizotinib) · Pfizer

Patent Metadata

Patent number: AU2010344973B2
Jurisdiction: AU
Classification: —
Expires: 2016-06-16
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.